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Abstract
Current Bayesian microarray models that pool multiple studies assume gene expression is independent of other genes.
However, in prokaryotic organisms, genes are arranged in units that are co-regulated (called operons). Here, we introduce a
new Bayesian model for pooling gene expression studies that incorporates operon information into the model. Our
Bayesian model borrows information from other genes within the same operon to improve estimation of gene expression.
The model produces the gene-specific posterior probability of differential expression, which is the basis for inference. We
found in simulations and in biological studies that incorporating co-regulation information improves upon the
independence model. We assume that each study contains two experimental conditions: a treatment and control. We
note that there exist environmental conditions for which genes that are supposed to be transcribed together lose their
operon structure, and that our model is best carried out for known operon structures.
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for the gene effects, with the number of components unknown.
The number of components was calculated by first modeling a
large number, e.g. 10, and counting the number of non-empty
components in the observed results. Similar to Choi et al. [17],
Jung et al. [18] pooled standardized gene effect size estimates into
an overall mean effect across studies, and included a parameter of
inter-study variability in the model. Unlike these previous
methods, Conlon et al. ([19], [20]) introduced a Bayesian metaanalysis model that treated each study separately, combining only
probabilities of differential expression without integrating expression values. In a comparative study of Bayesian meta-analysis
models, Conlon et al. [20] found that combining only probabilities
of differential expression outperformed pooling expression measures across studies, for their data sets.
The current Bayesian meta-analysis models assume that the
average expression of a gene is independent of other genes.
However, in prokaryotic species, many genes are organized in
operons, which consist of two or more genes that are next to each
other on the chromosome and commonly transcribed. Genes
within an operon tend to have similar levels of expression (Xiao
et al. [23]); this fact is commonly used in predicting operon
structure (Sabatti et al. [24]; Bockhorst et al. [25]). More
specifically, Xiao et al. [23] examined 217 microarray experiments for 53 conditions of the bacterium Escherichia coli. They
found high correlation of expression among pairs of genes in
predicted operons (mean correlation 0.62), and correlation near
zero for randomly selected pairs of genes (mean correlation 0.012).
Based on these findings, Xiao et al. [23] developed a Bayesian
model for individual microarray studies that incorporated
predicted operon structure; this model borrowed information

Introduction
The wealth of gene expression data currently being produced
has created an urgent need for new statistical methods to analyze
and pool this information. A common goal of gene expression
studies is to identify genes that are differentially expressed between
two conditions, such as wildtype versus mutant or treatment versus
control. Bayesian and empirical Bayesian models have been
developed extensively for individual microarray studies (Baldi and
Long [1]; Efron et al. [2]; Newton et al. [3], [4]; Tseng et al. [5];
Broët et al. [6]; Ibrahim et al. [7]; Lönnstedt and Speed [8];
Townsend and Hartl [9]; Gottardo et al. [10]; Ishwaran and Rao
[11], [12]; Kendziorski et al. [13]; Do et al. [14]; Lönnstedt and
Britton [15]), and several Bayesian approaches have recently been
introduced to combine multiple microarray studies (Choi et al.
[16]; Shen et al. [17]; Jung et al. [18]; Conlon et al. [19], [20];
Scharpf et al. [21]; see also Tseng et al. [22] for a comprehensive
review of meta-analysis methods). Choi et al. [16] introduced the
first Bayesian meta-analysis model to detect differentially expressed genes between two experimental conditions. This
approach combined standardized gene effects into an overall
mean effect across studies, and included an inter-study variability
parameter in the model. Shen et al. [17] implemented a Bayesian
model within each separate study to transform gene expression
measures to expression probabilities. The converted data was
pooled across studies to identify prognostic markers for disease. In
this method, Bayesian models were used for data pre-processing,
but not as a data integration procedure. Jung et al. [18]
introduced a Bayesian model-based clustering method for metaanalysis to identify differentially-expressed genes between two
samples. This model specified a normal mixture prior distribution
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For oligonucleotide array studies:

across genes within an operon to estimate gene expression levels.
The authors found that incorporating operon structure into the
model improved the detection of differentially expressed genes
versus an independence model for one study. Additional Bayesian
models for individual microarray studies have included operon
structure as prior information in the models (Price et al. [26]; Pin
et al. [27]). However, operon structure has not previously been
incorporated into Bayesian meta-analysis models for microarray
data. Here, we develop a new Bayesian meta-analysis model that
incorporates operon information into the model. Our Bayesian
meta-analysis operon model borrows information from genes
within the same operon; our model then produces the posterior
probability of differential expression for each gene. This posterior
probability of differential expression is the basis for inference. We
found in simulations of two and five studies that our operon model
outperformed the independence model by using three comparison
measures: the proportion of true genes discovered in meta-analysis
versus individual studies, the number of true genes discovered for
fixed levels of Bayesian false discovery, and the number of true
discoveries for a fixed top number of genes. When pooling two
Geobacter (G.) sulfurreducens microarray studies, we show that the
operon model produces higher proportions of discovered genes in
meta-analysis versus separate analyses than the independence
model. In addition, for the same thresholds of Bayesian false
discovery, we illustrate that the operon model identifies more
discoveries than the independence model for this biological data.
We note that there exist environmental conditions for which genes
that are supposed to be transcribed together lose their operon
structure, and that our model is best carried out for known operon
structures.

yjgbse Dvjgse *N(vjgse ,w2j ), j~(JSA z1),:::,J; g~1,:::,G;
b~1,:::,Bg ; s~1,:::,Se ; e~1,:::,E
vjgse Dmjge *N(mjge ,t2jg ), j~(JSA z1),:::,J; g~1,:::,G;
s~1,:::,Se ; e~1,:::,E
mjge Dhjg *N(hjg ,s2jg ), j~(JSA z1),:::,J; g~1,:::,G; e~1,:::,E

For all studies:
hjg DIg ~0*N(0,g2jg0 ), j~1, . . . ,J
hjg DIg ~1*N(0,cj |g2jg0 ), j~1, . . . ,J

p*Uniform(0,1)

For the spotted array studies, the yjgse are the observed data, and
are the normalized log-expression ratios for study j, gene g, slide s,
and experiment e. These are the log-ratios of fluorescent intensity
levels for the mRNA of the control and treatment samples, which
are labelled green and red (Cy3 and Cy5). The yjgse values are
standardized so that each slide had zero mean and unit standard
deviation (see also Shen et al. [17]; Conlon et al. [19], [20]). This
model takes into account that the yjgse are influenced by slide and
experiment variance. Within each study, yjgse is modeled as a
sample from a normal distribution of gene-specific slide values
within an experiment, denoted as yjgse *N(mjge ,t2jg ). Here mjge is
the gene-specific average of all slide values in an experiment, and
t2jg represents the slide variability. In turn, the within-experiment
mean mjge is modeled as a sample from a normal distribution of
experiment values, denoted as mjge *N(hjg ,s2jg ). Here, hjg is the
average log-expression ratio of gene g for study j, and s2jg indicates
the experiment variance.
For the oligonucleotide microarrays, termed in-situ synthesized
oligonucleotide (ISO) arrays, each gene is characterized by up to
four probes on each array (further detail is provided in Appendix
S1: Biological data). For Model (1), the yjgbse are the normalized
log-ratios of expression for study j, gene g, probe b, slide s, and
experiment e. These are again the ratio of fluorescent intensity
levels for the treatment and control mRNA samples, labelled red
and green (Cy5 and Cy3), standardized so that each slide had zero
mean and unit standard deviation. Here, the yjgbse are influenced
by the probe, slide and experiment variance. For each study, the
yjgbse are modeled as gene-specific samplings from normal
distributions of probe values within each slide. This is denoted
as yjgbse *N(vjgse ,w2j ), where vjgse is the mean among all probe
values for a slide for each gene, and w2j represents the variability

Methods
Bayesian Meta-analysis Independence Model
Biologists frequently carry out independent microarray studies
for the same biological system or pathway; often using different
technologies. For example, Methé et al. [28] used spotted DNA
microarrays to examine nitrogen fixation in G. sulfurreducens.
Alternatively, Postier et al. [29] studied this same pathway using
CombiMatrix short oligonucleotide arrays (for further details of
the biological data, see Appendix S1: Biological data). By
combining the two studies, we increase the sample size and more
precisely identify true target genes. More broadly, data typically
consists of multiple independent studies for one biological system,
with two conditions: a treatment and control; Bayesian metaanalysis models integrate this information in a systematic way. The
following model combines studies from two different platforms,
spotted and oligonucleotide arrays, and assumes that the average
expression of a gene is independent of other genes. It is similar to
the model introduced by Conlon et al. [19]; the spotted array
study consists of replicate slides within repeated experiments, and
the oligonucleotide array study contains multiple probes, slides
and experiments. We specify Model (1) as follows.
For spotted array (SA) studies:

across probes. A common probe variance w2j is assumed; this value
is calculated from the data, similar to other approaches (e.g. Xiao
et al. [23]). The within-slide mean vjgse denotes a sampling from a
normal distribution of slide values; this is modeled as
vjgse *N(mjge ,t2jg ). Here, mjge is again the gene-specific average
for all slide values of an experiment, and t2jg again measures the
slide variability. The remaining parameters are as described
previously for spotted arrays.

yjgse Dmjge *N(mjge ,t2jg ), j~1,:::,JSA ; g~1,:::,G; s~1,:::,Se ;
e~1,:::,E
mjge Dhjg *N(hjg ,s2jg ), j~1,:::,JSA ; g~1,:::,G; e~1,:::,E
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Figure 1. Results for the two-study simulation data with simulated percent differentially expressed genes ps = 5%. a) True integrationdriven discovery rate (tIDR) versus levels of posterior probability of differential expression c $0.50, for Model (1) (triangles) and Model (2) (circles); b)
The maximum number of true genes discovered versus posterior expected false discovery rate (peFDR) for Model (1) (triangles), Model (2) (circles),
individual analyses of Study 1 (checks), Study 2 (diamonds).
doi:10.1371/journal.pone.0052137.g001

The hjg values are modeled as a normal distribution with mean
zero and small variance for non-expressed genes, and with large
variance for differentially expressed genes. Note that Model (1)
specifies each study individually, and does not pool the mean
expression values for each study into an overall mean. In addition,
only the yjgse and yjgbse values are observed; the remaining model
parameters are unobserved.
We define Ig , Bernoulli(p) as the gene-specific indicator
variable for differential expression, i.e. hjg ? 0, j = 1,…, J, where p
is the percent of differentially expressed genes. Thus, Prob(Ig = 1) = p, where

Here, genes are separated into two groups, non-expressed (Ig = 0)
and differentially expressed (Ig = 1) with probabilities (1-p) and p,
respectively. When Ig = 0, the hjg are modeled as normally
distributed around zero with small varianceg2jg0 ; when Ig = 1, the
hjg are modeled as normally distributed around zero with large
variance cj |g2jg0 . Model (1) produces the gene-specific posterior
probability of differential expression, Dg = Prob(Ig = 1 | data),
which is used for inference.

Bayesian Meta-analysis Operon Model
The previous Model (1) assumed that the average expression for
a gene is independent of other genes. However, in prokaryotic
genomes, many genes are organized in operons, which are
commonly transcribed. Thus, genes in the same operon tend to
have similar expression levels. Here, we introduce a new Bayesian
meta-analysis model that incorporates predicted operon structure


0 if hjg ~0, j~1, . . . ,J
Ig ~
1 if hjg =0, j~1, . . . ,J
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The valuesyjgse ,yjgbse ,mjge ,vjgse ,t2jg ,s2jg ,w2j are as described above
for Model (1). For hjg, if gene g is a member of operon On, the hjg
values are assumed to be normally distributed with the average
expression equal to that of operon n in study j, with n2j the studyspecific operon variability. If gene g is not a member of any operon
On, hjg is treated separately from other genes. Here, n ranges from 1
to the total number of operons N plus the number of genes not
included in any operon N9. Similar to Model (1), Model (2)
specifies each study separately, and does not combine mean
expression levels for each study into an overall mean value. The
normal assumption for log-expression ratios of genes organized in
operons has been used by many previous authors, including Wang
and Zhang [30], Price et al. [26], Xiao et al. [23], Iber [31], de
Hoon et al. [32], Segal et al. [33]. In repeated microarray
experiments, it is typical to model the log-expression ratios with
a normal distribution. For genes organized in operons, the same
bases for the model assumptions apply. We assume that genes
within the same operon will have the same expression pattern for
ratios between two conditions, on the log scale, for a steady-state
condition. We assume that there will be some systematic error
around the average log-expression ratio within an operon. Some
genes will have log-ratios with higher values than the mean, and
some will have lower, but the distribution will center with the
highest probability at the mean, and lower probability for values
much higher and lower. Thus, the log-ratios of expression for
genes within an operon are assumed normally distributed.
We define In , Bernoulli(p) as the indicator variable for
differential expression, i.e. jjn ? 0, j = 1,…, J, where p is the
percent of differentially expressed genes. Thus, Prob(In = 1) = p,
where

into the model. Our model borrows information across operons,
and used a weighted average of the individual gene’s expression
level and the operon expression level to estimate expression for
each gene. The weights are inversely proportional to the variances.
Our Model (2) to incorporate operon information is as follows.
For spotted array (SA) studies:
yjgse Dmjge *N(mjge ,t2jg ), j~1,:::,JSA ; g~1,:::,G; s~1,:::,Se ;
e~1,:::,E
mjge Dhjg *N(hjg ,s2jg ), j~1,:::,JSA ; g~1,:::,G; e~1,:::,E
For oligonucleotide array studies:
yjgbse Dvjgse *N(vjgse ,w2j ), j~(JSA z1),:::,J; g~1,:::,G;
b~1,:::,Bg ; s~1,:::,Se ; e~1,:::,E
vjgse Dmjge *N(mjge ,t2jg ), j~(JSA z1),:::,J; g~1,:::,G;
s~1,:::,Se ; e~1,:::,E
mjge Dhjg *N(hjg ,s2jg ), j~(JSA z1),:::,J; g~1,:::,G; e~1,:::,E

For all studies:
hjg *N(jjn ,n2j ), j~1,:::,J,for g[On for some n~1, . . . ,N
hjg :jjn , j~1,:::,J,for g=[On for any n,


0 if jjn ~0, j~1, . . . ,J
In ~
1 if jjn =0, j~1, . . . ,J

0

n~(Nz1), . . . ,(NzN )
jjn DIn ~0*N(0,g2jg0 ), j~1,:::,J; n~1,:::,(NzN 0 )

ð2Þ

jjn DIn ~1*N(0,cj |g2jg0 ), j~1,:::,J; n~1,:::,(NzN 0 )

Here, genes are separated into two groups, non-expressed (In = 0)
and expressed (In = 1) with probabilities (1-p) and p, respectively.
When In = 0, the jjn are assumed to be normally distributed with
mean zero and small varianceg2jg0 ; when In = 1, the jjn are assumed
to be normally distributed with mean zero and large variance
cj |g2jg0 . For each gene, Model (2) produces the posterior

In *Bernoulli(p)
p*Uniform(0,1),

Table 1. Simulation results for two and five studies.

Ps = 5%
Model (1)

Ps = 10%
Model (2)

Model (1)

Ps = 25%
Model (2)

Model (1)

Model (2)

Two-Study Simulation Data
tIDR, c = 0.95

12.9%

25.9%

6.5%

21.9%

2.6%

15.3%

True Genes, peFDR = 0.05

102

122

207

245

544

614

True Genes, Fixed Top ps%

111

127

232

259

609

657

Five-Study Simulation Data
tIDR, c = 0.95

5.3%

9.9%

1.9%

6.1%

1.6%

4.2%

True Genes, peFDR = 0.05

141

150

277

293

719

735

True Genes, Fixed Top ps%

142

149

278

294

714

735

True integration-driven discovery rate (tIDR) for posterior probability of differential expression c = 0.95, the number of true genes discovered for posterior expected false
discovery rate peFDR = 5%, and the number of true genes discovered for a fixed top number of genes. Results are shown for Models (1) and (2), and for the three values
of simulated percent differentially expressed genes ps.
doi:10.1371/journal.pone.0052137.t001
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Figure 2. Results for the five-study simulation data with simulated percent differentially expressed genes ps = 5%. a) True integrationdriven discovery rate (tIDR) versus levels of posterior probability of differential expression c $0.50, for Model (1) (triangles) and Model (2) (circles); b)
The maximum number of true genes discovered versus posterior expected false discovery rate (peFDR) for Model (1) (triangles), Model (2) (circles),
individual analyses of Study 1 (checks), Study 2 (diamonds), Study 3 (pluses), Study 4 (inverted triangles), Study 5 (stars).
doi:10.1371/journal.pone.0052137.g002

study. Note that we specify a common parameter for variance over
all operons within each study (similar to Xiao et al. [23]). Further
details on prior distributions are provided in Appendix S2: Prior
distributions. The prior structure for Models (1) and (2) for
individual studies is similar to that of Gottardo et al. [10], except
that Models (1) and (2) generate posterior distributions for p, while
Gottardo et al. calculate p using an iterative algorithm. Our data
sets also have more levels of replication than the model of
Gottardo et al., i.e. multiple probes, slides and experiments. The
hierarchical structure of Models (1) and (2) for individual studies is
also similar to the Bayesian ANOVA models (BAM) of Ishwaran
and Rao [11], [12]. BAM redefines the identification of
differentially expressed genes as a variable selection procedure,
and employs a Bayesian model designed for adaptive shrinkage.
Models (1) and (2) differ from BAM for individual studies,
however, since BAM models are constructed for two-sample rather

probability of differential expression, Dg = Prob(In = 1 | data),
which is the basis for inference.

Prior Distributions for Models (1) and (2)
For prior distributions, we assign distributions that are as
uninformative as possible which still result in convergence of the
models. For parameters common to both Models (1) and (2), we
assigned conjugate scaled inverse chi-squared prior distributions to
the experiment, slide and probe variance parameters, s2jg , t2jg , and
w2j , respectively. The scale parameters are derived from the data,
by pooling information from all genes (similar to Tseng et al. [5];
Lönnstedt and Speed [8]; Gottardo et al. [10]; Conlon et al. [19],
[20]). For Model (2), the prior distribution of operon variability n2j
was assigned an inverse chi-squared distribution, with scale
parameter equivalent to the variability within operons of each
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with dg an indicator variable for differentially expressed genes and
Y representing the data (see also Do et al. [14]). Note that Conlon
et al. [19] compared true FDR to peFDR in several simulation
studies and found that the two measures were always within 3% of
each other on average. In addition, the peFDR was a conservative
estimate of true FDR in these simulation studies.

than one-sample data; Models (1) and (2) also have more levels of
data replication. We produce posterior distributions for model
parameters by implementing a Markov chain Monte Carlo
(MCMC) procedure (details provided in Appendix S2). We
calculate gene-specific posterior probabilities of differential
expression for Models (1) and (2); the models are then compared
using integration-driven discovery and Bayesian false discovery,
defined in the following sections.

Results

Markov Chain Monte Carlo Procedure

Simulation Results for Two Studies

For the simulation data, true genes are defined as those that were
simulated to be differentially expressed. The true integrationdriven discovery rate, tIDR, is the proportion of true genes
discovered in meta-analysis but not in any of the separate studies:

We simulated data for two studies similar to the biological data;
Study 1 was specified to resemble the spotted array study, and
Study 2 was similar to the ISO array study. We simulated a total of
3,000 genes and three values for the percent of differentially
expressed genes: ps = 5%, 10%, 25% (ps denoting simulated); each
slide was also standardized to have mean zero and unit standard
deviation (similar to Shen et al. [17]; Conlon et al. [19], [20]). We
simulated the operon structure similar to the predicted operon
structure of the biological data. For genes within the same operon,
we assumed a common average gene expression level, with
variance again corresponding to the biological data. Appendix S1
provides further details on the simulation procedure.
We implemented Models (1) and (2) for the meta-analysis of two
studies; each study was also analyzed separately using j = 1. Results
are discussed here for the data set with ps = 5%. To compare
Models (1) and (2), we calculated for both models the true
integration-driven discovery rate (tIDR) for fixed levels of c $0.50,
which correspond to posterior probabilities of differential expression greater or equal to 50%. Model (2) produced higher tIDR
than Model (1) for all values of c $0.50 (Figure 1a). We also fixed
threshold levels of peFDR and found that Model (2) discovered
more true genes than Model (1) for the same levels of peFDR
,20%; both models improved discoveries versus separate analyses
(Figure 1b). Similar results for tIDR and peFDR were determined
for the data sets with ps = 10%, 25% (Table 1).
In addition to tIDR and peFDR, researchers are often interested
in the top set of genes only, e.g. the top 100 genes. For this reason,
we ranked the genes based on Dg in both Models (1) and (2) and
compared the resulting numbers of true genes included in the top
set of genes. Here, we chose a threshold of the top ps% of genes.
We found that Model (2) identified more true genes than Model
(1), for all data sets (Table 1).

tIDR(c)

Simulation Results for Five Studies

We produce posterior distributions for model parameters by
implementing a Markov chain Monte Carlo (MCMC) algorithm
(details provided in Appendix S2). For the operon model, the
estimated expression level of a gene is a weighted average of the
gene-specific and operon-specific mean expression levels. The
weights are inversely proportional to the variance values. We
calculate gene-specific posterior probabilities of differential
expression for Models (1) and (2); the models are then compared
using integration-driven discovery and Bayesian false discovery,
defined in the following sections. More detail on the MCMC
implementation is provided in Appendix S2.

Integration-driven Discovery
Choi et al. [16] introduced the integration-driven discovery rate
(IDR) as the proportion of genes determined to be differentially
expressed in meta-analysis but not in any of the individual studies
alone. IDR depicts the gain in information from combining studies
compared to individual analyses. We fix the threshold level of
posterior probability of differential expression, c, and label genes
as differentially expressed if (Dg $ c). Specifically, IDR is defined
as follows:
IDR(c)
~

~

# genes ½(Dg §c) in meta-analysis and ½(Dg vc) in all individual studies
:
#genes ½(Dg §c) in meta-analysis

We also implemented Models (1) and (2) to combine five
independent studies. For this, we produced three additional
simulation studies: one with a design similar to Study 1, and two
with designs similar to Study 2. The simulation parameters were
either within the range of the biological data, or somewhat outside
the range; Appendix S1 provides further details on the simulation
procedure. We again simulated three levels for the percent of
differentially expressed genes: ps = 5%, 10%, 25%.
For the data set corresponding to ps = 5%, Model (2) again
identified higher tIDR than Model (1) for all levels of c $0.50
(Figure 2a). In comparison to the two-study simulations, integrating more studies resulted in lower average tIDR for c $50% for
both Models (1) and (2). This occurred since, for larger numbers of
studies, it was more likely that some genes had Dg $ c in at least
one individual study, which reduced tIDR. Similar results were
established for the data sets with ps = 10%, 25% (Table 1).
When combining five studies, both Models (1) and (2) identified
more true discoveries than separate analyses for the same
thresholds of peFDR; Model (2) again discovered more true genes
than Model (1), similar to the two-study findings (Figure 2b). In

# true genes ½(Dg §c) in meta-analysis and ½(Dg vc) in all individual studies
:
# true genes ½(Dg §c) in meta-analysis

Bayesian False Discovery Rate
The false discovery rate (FDR) was introduced by Benjamini
and Hochberg [34] and is defined as the expected number of
discoveries that are not truly differentially expressed divided by the
total number of discoveries. Further analyses and discussions of
FDR for microarray data are provided in Tusher et al. [35],
Genovese and Wasserman [36], Storey [37] and Storey and
Tibshirani [38]. For Bayesian analyses, Genovese and Wasserman
[39] introduced the posterior expected FDR (peFDR) as:
P
peFDR~E(FDRDY )~

g

(1{Dg )dg
P
,
dg
g
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produced higher IDR than Model (1) for all levels of c $0.50
(Figure 3a). For fixed values of peFDR ,20%, both Models (1) and
(2) discovered more genes than the individual studies alone, and
Model (2) discovered more genes than Model (1) for all values
(Figure 3b).

comparison to the two-study simulations, pooling more studies
produced more true discoveries for the same levels of peFDR, for
both models. This indicates that combining more data improves
the accuracy of peFDR. When examining the top 150 genes (i.e.
the top ps%), Model (2) again identified more true genes than
Model (1), and pooling more studies improved the results versus
the two study simulations. We found similar results for peFDR and
the top sets of genes for ps = 10%, 25% (Table 1).

Discussion
Here, we developed a new Bayesian meta-analysis model that
incorporates operon information into the model. By borrowing
information across genes in the same operon, we improved results
versus previous Bayesian meta-analysis models that assume
expression of a gene is independent of other genes. In simulations
of two and five studies, we found that the operon model
outperformed the independence model using three common
comparison measures: the percent of true genes discovered in
meta-analysis but not in separate studies, the number of true genes

Biological Data Results
We implemented Models (1) and (2) to combine the nitrogen
fixation data of G. sulfurreducens for the spotted array and ISO array
studies; we also analyzed each study separately. In total, there were
3,323 genes that had expression in both studies (for further details
of the biological data, see Appendix S1: Biological data). For IDR,
our results were similar to the simulations studies; Model (2)

Figure 3. G. sulfurreducens spotted array and ISO array study data results. a) Integration-driven discovery rate (IDR) versus levels of posterior
probability of differential expression c $0.50, for Model (1) (triangles) and Model (2) (circles); b) The maximum number of genes discovered versus
posterior expected false discovery rate (peFDR) for Model (1) (triangles), Model (2) (circles), separate analyses of the G. sulfurreducens spotted array
study (checks) and ISO array study (diamonds).
doi:10.1371/journal.pone.0052137.g003
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identified for the same thresholds of Bayesian false discovery, and
the number of true genes discovered for a fixed top number of
genes. For the biological data of G. sulfurreducens, the operon model
produced higher integration-driven discovery rates for the same
thresholds of posterior probability of differential expression than
the independence model. The operon model also discovered more
genes than the independence model for fixed levels of Bayesian
false discovery. We note that Xiao et al. [23] introduced a
Bayesian model for one study that incorporates operon information into the model. The operon model was shown to improve
gene expression estimates compared to the independence model
for one study. Here, we extended this model for multiple studies,
showing similar improvement for the meta-analysis framework.
Our Bayesian meta-analysis operon model used the assumption
that genes in an operon are co-transcribed. There are some cases
where genes from an operon are expressed at different levels. First,
genes may express differently due to their location in the operon.
However, as discussed in Price et al. [26], in steady state cases,
these differences do not affect the ratios of expression between the
two experimental conditions; thus, expression ratios should be
similar across an operon. Second, small noncoding RNAs can bind
to specific transcripts and cause them to increase or decrease
stability. However, in practical terms, genes in the same operon

typically show similar patterns of expression, and patterns of
expression are used to predict genes in the same operon (see also
Sabatti et al. [24]; Price et al. [26]).

Supporting Information
Appendix S1

Description of simulation data sets and biological

data sets.
(DOC)
Appendix S2 Details of the Markov chain Monte Carlo

implementation.
(DOC)
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